Conor Burke explores the results of a survey and offers advice at a time when a good relationship between industry and the NHS has never been more important
The NHS and life-sciences industry serve a common purpose: to improve population and patient health and wellbeing. Over many years, a range of initiatives have been established to encourage and promote greater collaboration between the sectors.
Industry has significant skills and resources that could be utilised more effectively by the NHS, and the NHS offers a unique opportunity to develop and test new products and services. This would benefit the UK economy and population, as well as providing a test‑bed for global developments.
Industry has significant skills and resources that could be utilised more effectively by the NHS …
However, despite many attempts to promote better governance, increase transparency, and develop more collaborative working,1–3 there remains a gap between understanding the importance of the opportunity and making it happen on the ground.
The lack of enthusiasm for collaboration has been exacerbated by headlines such as ‘Who let the drug companies in?’4 and other media coverage suggesting that the NHS is being held to ransom by pharmaceutical companies.5,6